Facebook Linkedin RSS Twitter Youtube
Home 2021

Ebola vaccine

Ebola Vaccine Good News: Clinical Trial Shows Strong Immune Response
Drug Discovery

Ebola Vaccine Good News: Clinical Trial Shows Strong Immune Response

Julianna LeMieux, PhD -
0
Why Biopharma Should Consider Plant-Based Manufacturing
Bioprocessing

Why Biopharma Should Consider Plant-Based Manufacturing

John Sterling -
0
Gene Therapy Advanced by Structural Study of Potential Viral Vectors
Drug Discovery

Gene Therapy Advanced by Structural Study of Potential Viral Vectors

GEN Staff Writer -
1
Integral Molecular Sizes Up Ebola
News

Integral Molecular Sizes Up Ebola

Gail Dutton -
0
Bavarian Nordic Wins Up-to-$33M Janssen Subcontract for Ebola Vaccine Regimen
Bioprocessing

Bavarian Nordic Wins Up-to-$33M Janssen Subcontract for Ebola Vaccine Regimen

GEN Staff Writer -
0
Merck-NewLink Genetics Ebola Vaccine Shows 100% Efficacy in Phase III Trial
Drug Discovery

Merck-NewLink Genetics Ebola Vaccine Shows 100% Efficacy in Phase III Trial

GEN Staff Writer -
0
NewLink Wins $20M from Merck & Co. for Ebola Vaccine Trial Launch
Drug Discovery

NewLink Wins $20M from Merck & Co. for Ebola Vaccine Trial Launch

GEN Staff Writer -
0
GSK Ebola Vaccine Shipped to Liberia for Phase III Trial
Infectious Diseases

GSK Ebola Vaccine Shipped to Liberia for Phase III Trial

GEN Staff Writer -
0
Consortium Wins $115M toward Work with J&J on Ebola Vaccine
Drug Discovery

Consortium Wins $115M toward Work with J&J on Ebola Vaccine

GEN Staff Writer -
0
Gavi Commits $390M Toward Ebola Efforts
Infectious Diseases

Gavi Commits $390M Toward Ebola Efforts

GEN Staff Writer -
0
12Page 1 of 2
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.